Corrigendum: Efficacy of ixekizumab in patients with moderate-to-severe plaque psoriasis and prediabetes or type 2 diabetes

Saved in:
Bibliographic Details
Main Authors: Egeberg, Alexander (Author) , Merola, Joseph F. (Author) , Schäkel, Knut (Author) , Puig, Luis (Author) , Mahar, Patrick D. (Author) , Wang, Isabella Yali (Author) , Pavo, Imre (Author) , Schuster, Christopher (Author) , Griffiths, Christopher E. M. (Author)
Format: Article (Journal)
Language:English
Published: 10 March 2023
In: Frontiers in medicine
Year: 2023, Volume: 10, Pages: 1-2
ISSN:2296-858X
DOI:10.3389/fmed.2023.1171132
Online Access:Resolving-System, kostenfrei, Volltext: https://doi.org/10.3389/fmed.2023.1171132
Verlag, lizenzpflichtig, Volltext: https://www.frontiersin.org/articles/10.3389/fmed.2023.1171132
Get full text
Author Notes:Alexander Egeberg, Joseph F. Merola, Knut Schäkel, Luis Puig, Patrick D. Mahar, Isabella Yali Wang, Imre Pavo, Christopher Schuster and Christopher E.M. Griffiths

MARC

LEADER 00000caa a2200000 c 4500
001 1854984101
003 DE-627
005 20241112082350.0
007 cr uuu---uuuuu
008 230809s2023 xx |||||o 00| ||eng c
024 7 |a 10.3389/fmed.2023.1171132  |2 doi 
035 |a (DE-627)1854984101 
035 |a (DE-599)KXP1854984101 
035 |a (OCoLC)1425213033 
040 |a DE-627  |b ger  |c DE-627  |e rda 
041 |a eng 
084 |a 33  |2 sdnb 
100 1 |a Egeberg, Alexander  |d 1989-  |e VerfasserIn  |0 (DE-588)1185508376  |0 (DE-627)1664853316  |4 aut 
245 1 0 |a Corrigendum: Efficacy of ixekizumab in patients with moderate-to-severe plaque psoriasis and prediabetes or type 2 diabetes  |c Alexander Egeberg, Joseph F. Merola, Knut Schäkel, Luis Puig, Patrick D. Mahar, Isabella Yali Wang, Imre Pavo, Christopher Schuster and Christopher E.M. Griffiths 
264 1 |c 10 March 2023 
300 |a 2 
336 |a Text  |b txt  |2 rdacontent 
337 |a Computermedien  |b c  |2 rdamedia 
338 |a Online-Ressource  |b cr  |2 rdacarrier 
500 |a Gesehen am 09.08.2023 
700 1 |a Merola, Joseph F.  |e VerfasserIn  |4 aut 
700 1 |a Schäkel, Knut  |e VerfasserIn  |0 (DE-588)1032757418  |0 (DE-627)739272896  |0 (DE-576)251064476  |4 aut 
700 1 |a Puig, Luis  |e VerfasserIn  |4 aut 
700 1 |a Mahar, Patrick D.  |e VerfasserIn  |4 aut 
700 1 |a Wang, Isabella Yali  |e VerfasserIn  |4 aut 
700 1 |a Pavo, Imre  |e VerfasserIn  |4 aut 
700 1 |a Schuster, Christopher  |e VerfasserIn  |4 aut 
700 1 |a Griffiths, Christopher E. M.  |e VerfasserIn  |4 aut 
773 0 8 |i Enthalten in  |t Frontiers in medicine  |d Lausanne : Frontiers Media, 2014  |g 10(2023) vom: März, Artikel-ID 1171132, Seite 1-2  |h Online-Ressource  |w (DE-627)789482991  |w (DE-600)2775999-4  |w (DE-576)408729597  |x 2296-858X  |7 nnas  |a Corrigendum: Efficacy of ixekizumab in patients with moderate-to-severe plaque psoriasis and prediabetes or type 2 diabetes 
773 1 8 |g volume:10  |g year:2023  |g month:03  |g elocationid:1171132  |g pages:1-2  |g extent:2  |a Corrigendum: Efficacy of ixekizumab in patients with moderate-to-severe plaque psoriasis and prediabetes or type 2 diabetes 
787 0 8 |i Errata zu  |a Egeberg, Alexander, 1989 -   |t Efficacy of ixekizumab in patients with moderate-to-severe plaque psoriasis and prediabetes or type 2 diabetes  |d 2022  |w (DE-627)1843316676 
856 4 0 |u https://doi.org/10.3389/fmed.2023.1171132  |x Resolving-System  |x Verlag  |z kostenfrei  |3 Volltext 
856 4 0 |u https://www.frontiersin.org/articles/10.3389/fmed.2023.1171132  |x Verlag  |z lizenzpflichtig  |3 Volltext 
951 |a AR 
992 |a 20230809 
993 |a Article 
994 |a 2023 
998 |g 1032757418  |a Schäkel, Knut  |m 1032757418:Schäkel, Knut  |d 910000  |d 911300  |e 910000PS1032757418  |e 911300PS1032757418  |k 0/910000/  |k 1/910000/911300/  |p 3 
999 |a KXP-PPN1854984101  |e 4364067172 
BIB |a Y 
SER |a journal 
JSO |a {"name":{"displayForm":["Alexander Egeberg, Joseph F. Merola, Knut Schäkel, Luis Puig, Patrick D. Mahar, Isabella Yali Wang, Imre Pavo, Christopher Schuster and Christopher E.M. Griffiths"]},"recId":"1854984101","note":["Gesehen am 09.08.2023"],"origin":[{"dateIssuedKey":"2023","dateIssuedDisp":"10 March 2023"}],"id":{"eki":["1854984101"],"doi":["10.3389/fmed.2023.1171132"]},"language":["eng"],"type":{"media":"Online-Ressource","bibl":"article-journal"},"person":[{"role":"aut","family":"Egeberg","display":"Egeberg, Alexander","given":"Alexander"},{"role":"aut","family":"Merola","display":"Merola, Joseph F.","given":"Joseph F."},{"family":"Schäkel","display":"Schäkel, Knut","given":"Knut","role":"aut"},{"given":"Luis","family":"Puig","display":"Puig, Luis","role":"aut"},{"display":"Mahar, Patrick D.","family":"Mahar","given":"Patrick D.","role":"aut"},{"given":"Isabella Yali","display":"Wang, Isabella Yali","family":"Wang","role":"aut"},{"display":"Pavo, Imre","family":"Pavo","given":"Imre","role":"aut"},{"role":"aut","display":"Schuster, Christopher","family":"Schuster","given":"Christopher"},{"role":"aut","family":"Griffiths","display":"Griffiths, Christopher E. M.","given":"Christopher E. M."}],"physDesc":[{"extent":"2 S."}],"title":[{"title":"Corrigendum: Efficacy of ixekizumab in patients with moderate-to-severe plaque psoriasis and prediabetes or type 2 diabetes","title_sort":"Corrigendum: Efficacy of ixekizumab in patients with moderate-to-severe plaque psoriasis and prediabetes or type 2 diabetes"}],"relHost":[{"disp":"Corrigendum: Efficacy of ixekizumab in patients with moderate-to-severe plaque psoriasis and prediabetes or type 2 diabetesFrontiers in medicine","recId":"789482991","pubHistory":["2014 -"],"note":["Gesehen am 09.02.2021"],"type":{"media":"Online-Ressource","bibl":"periodical"},"id":{"eki":["789482991"],"issn":["2296-858X"],"zdb":["2775999-4"]},"language":["eng"],"origin":[{"dateIssuedDisp":"2014-","publisherPlace":"Lausanne","dateIssuedKey":"2014","publisher":"Frontiers Media"}],"title":[{"title":"Frontiers in medicine","title_sort":"Frontiers in medicine"}],"titleAlt":[{"title":"FMED"},{"title":"Front. Med."}],"physDesc":[{"extent":"Online-Ressource"}],"part":{"text":"10(2023) vom: März, Artikel-ID 1171132, Seite 1-2","pages":"1-2","extent":"2","year":"2023","volume":"10"}}]} 
SRT |a EGEBERGALECORRIGENDU1020